{"database": "lobbying", "table": "lobbying_activities", "rows": [[2503528, "75a56750-cc95-49bd-b1d6-cea7bf27b3f9", "Q3", "MERCURY PUBLIC AFFAIRS, LLC", 70175, "EMERGENT BIOSOLUTIONS INC", 2020, "third_quarter", "HCR", "Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government", "Office of Administration,White House Office", 50000, null, 0, 0, "2020-10-02T15:00:30.350000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2503528"], "units": {}, "query_ms": 11.456546024419367, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}